Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction

被引：0

作者：

Meifan Zheng

Nan Lu

Meixia Ren

Haifeng Chen

机构：

[1] Fujian Medical University,Department of Cardiology, Fujian Provincial Clinical College

[2] Hainan West Central Hospital,Department of Cardiology

[3] Fujian Medical University,Fujian Key Laboratory of Geriatrics, Department of Geriatric Medicine, Fujian Provincial Hospital

来源：

BMC Cardiovascular Disorders | / 20卷

关键词：

Acute myocardial infarction; Visfatin; Major adverse cardiovascular events;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
Zheng, Meifan
Lu, Nan
Ren, Meixia
Chen, Haifeng
[J]. BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
[2] Plasma visfatin levels are associated with major adverse cardiovascular events in patients with acute ST-elevation myocardial infarction
Hung, Wei-Chin
Yu, Teng-Hung
Hsu, Chia-Chang
Lu, Li-Fen
Chung, Fu-Mei
Tsai, I-Ting
Lu, Yung-Chuan
Houng, Jer-Yiing
Lee, Yau-Jiunn
Wang, Chao-Ping
[J]. CLINICAL AND INVESTIGATIVE MEDICINE, 2015, 38 (03): : E100 - E109
[3] Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction
Yuyun, Matthew Fomonyuy
Jutla, Sandeep K.
Quinn, Paulene A.
Ng, Leong L.
[J]. HEART ASIA, 2012, 4 (01) : 102 - 107
[4] Higher circulating visfatin levels are associated with increased risk of atrial fibrillation and major adverse cardiovascular events in patients with acute ST-elevation myocardial infarction
Hu, Heng-Jing
Qiu, Jie
Huang, Jia-Bing
Liu, Qi-Ming
Tang, Zhi-Han
Qu, Shun-Lin
Jiang, Zhi-Sheng
[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (02): : 2062 - 2070
[5] Predicting Major Adverse Events in Patients With Acute Myocardial Infarction
Nestelberger, Thomas
Boeddinghaus, Jasper
Wussler, Desiree
Twerenbold, Raphael
Badertscher, Patrick
Wildi, Karin
Miro, Oscar
Lopez, Beatriz
Javier Martin-Sanchez, F.
Muzyk, Piotr
Koechlin, Luca
Baumgartner, Benjamin
Meier, Mario
Troester, Valentina
Gimenez, Maria Rubini
Puelacher, Christian
de Lavallaz, Jeanne du Fay
Walter, Joan
Kozhuharov, Nikola
Zimmermann, Tobias
Gualandro, Danielle M.
Michou, Eleni
Potlukova, Eliska
Geigy, Nicolas
Keller, Dagmar I.
Reichlin, Tobias
Mueller, Christian
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (07) : 842 - 854
[6] Clinical predictors of major adverse cardiovascular events after acute myocardial infarction in female patients
Danny, S. S.
Roebiono, P. S.
Soesanto, A. M.
[J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0A) : S22 - S22
[7] Interleukin-34 levels are increased in acute myocardial infarction and associated with major adverse cardiovascular events
Kashiwagi, Manabu
Ozaki, Yuichi
Imanishi, Toshio
Taruya, Akira
Kuroi, Akio
Katayama, Yosuke
Shimamura, Kunihiro
Shiono, Yasutsugu
Tanimoto, Takashi
Kubo, Takashi
Tanaka, Atsushi
Akasaka, Takashi
[J]. CORONARY ARTERY DISEASE, 2022, 31 (01) : 61 - 63
[8] Geographical Miss is Associated with Vulnerable Plaque and Increased Major Adverse Cardiovascular Events in Patients With Myocardial Infarction
Calvert, Patrick A.
Brown, Adam J.
Hoole, Stephen P.
Obaid, Daniel R.
West, Nick E. J.
Bennett, Martin R.
[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 88 (03) : 340 - 347
[9] High Lipoprotein(a) Levels as a Predictor of Major Adverse Cardiovascular Events in Hospitalized-Acute Myocardial Infarction Patients
Sumarjaya, I. Dewa Gde Dwi
Nadha, I. Ketut Badjra
Lestari, Anak Agung Wiradewi
[J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2020, 16 : 125 - 132
[10] Association between admission systolic blood pressure and major adverse cardiovascular events in patients with acute myocardial infarction
Pei, Junyu
Wang, Xiaopu
Xing, Zhenhua
Chen, Pengfei
Su, Wen
Deng, Simin
Hu, Xinqun
[J]. PLOS ONE, 2020, 15 (06):

← 1 2 3 4 5 →